Targeting the Serine Pathway: A Promising Approach against Tuberculosis?
Tuberculosis is still the leading cause of death by a single infectious agent. Effective chemotherapy has been used and improved since the 1950s, but strains resistant to this therapy and most antibacterial drugs on the market are emerging. Only 10 new drugs are in clinical trials, and two of them h...
Main Authors: | Marie Haufroid, Johan Wouters |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/12/2/66 |
Similar Items
-
Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of <i>Mycobacterium tuberculosis</i> Phosphoserine Phosphatase
by: Elise Pierson, et al.
Published: (2020-01-01) -
Validating the inhibitory effects of d- and l-serine on the enzyme activity of d-3-phosphoglycerate dehydrogenases that are purified from Pseudomonas aeruginosa, Escherichia coli and human colon
by: Jun Okuda, et al.
Published: (2019-06-01) -
Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells
by: Rumeysa Biyik-Sit, et al.
Published: (2021-08-01) -
Quantum Mechanical/Molecular Mechanical Analysis of the Catalytic Mechanism of Phosphoserine Phosphatase
by: Dieter Krachtus, et al.
Published: (2018-12-01) -
Glycerol Is an Osmoprotectant in Two Antarctic Chlamydomonas Species From an Ice-Covered Saline Lake and Is Synthesized by an Unusual Bidomain Enzyme
by: James A. Raymond, et al.
Published: (2020-08-01)